Utah HB 174: When Politics Overrides Medicine
Utah’s HB 174—Sex Characteristic Change Treatment Amendments—is part of a growing wave of legislation restricting access to gender affirming care for transgender and gender diverse (TGD) adolescents. We’re going to say this plainly: this law moved forward despite evidence, despite national standards of care, and despite Utah’s own commissioned review of the evidence.
Before we dive in, a quick but important note:
This blog is for educational purposes only and does not constitute legal advice. Laws change, interpretations of laws vary, and if you need legal guidance, you should consult a qualified attorney.
What HB 174 Actually Does
At a high level, HB 174 restricts access to gender affirming treatment (GAT) for adolescents and creates a clinical environment where providing care becomes significantly more difficult.
In practice, the law disrupts the patient–family–provider relationship, replacing clinical judgment with legislative control.
This is what it looks like when the government steps into the exam room and overrides individualized evidenced-based medicine.
Utah Ignored Its Own Evidence 🤔
Here’s the part that should stop everyone in their tracks.
Utah didn’t lack data. The state commissioned its own evidence review on gender affirming care for adolescents. That review found:
- Low rates of regret.
- Improved mental health outcomes
- A growing body of supportive evidence.
QueerDoc broke this down here:
👉https://queerdoc.com/utahs-evidence-review-on-gender-affirming-care-youth/
That’s not evidence-based policymaking. That’s choosing a conclusion first—and ignoring the data that doesn’t fit it.
A Direct Conflict with Medical Standards
Across the U.S., the majority of medical organizations support access to gender affirming care for appropriately- evaluated adolescents. These aren’t fringe opinions: they represent the consensus of decades of research and clinical expertise. Best practices in transgender healthcare center individualized treatment plans, informed consent, and meaningful involvement of families, all delivered by trained and experienced clinicians.
HB 174 doesn’t refine or improve this model of care—it restricts it. And in doing so, it places legislation in direct opposition to how evidence-based transgender medical care is actually meant to be practiced.
This Care Is Not New
Let’s gently (but firmly) retire the idea that gender affirming care is experimental.
Gender affirming treatment has existed in modern Western medicine for over 100 years. The evidence base has only grown stronger, with consistent findings that access to care is associated with:
- Reduced depression and anxiety.
- Lower rates of suicidality.
- Improved overall functioning.
Want receipts? We’ve got them:
👉 https://queerdoc.com/citations-supporting-adolescent-gender-care/
👉 https://www.oah.org/advocacy-statement/amicus-curiae-brief-in-us-v-skrmetti/
This is medically necessary, evidence-based care. Not hypothetical. Not emerging. Not experimental. Established.
The Double Standard
Here’s where things get uncomfortable but necessary.
We trust clinicians and families to make complex medical decisions for adolescents all the time when it comes to endocrinology. No one is proposing laws to restrict:
- Insulin for adolescents with diabetes.
- Treatment for precocious puberty.
But when the care is for transgender adolescents, suddenly it becomes political.
That inconsistency isn’t neutral. It reflects whose care is seen as valid —and whose isn’t.
What the Data Actually Shows: The Impact of Bans on Adolescents
If the stated goal of laws like HB 174 is to “protect” adolescents, then we need to ask a very basic question: what actually happens when access to care is restricted?
The answer is not subtle and it’s not reassuring.
A growing body of research shows that restricting access to gender affirming care is associated with worsening mental health outcomes for transgender adolescents. When adolescents can access care, we consistently see improvements in depression, anxiety, and suicidality. When that care is delayed or denied, those risks increase.
We’re not talking about small changes.
A 2024 Trevor Project study found that suicide attempt rates among transgender youth increased by as much as 72 percent in the first year after the adoption of state-level anti-transgender laws. That is a massive, measurable shift—and one that should be setting off alarms everywhere.
Human Rights Watch echoed these findings in their 2025 report, “They’re Ruining People’s Lives,” (https://www.hrw.org/report/2025/06/03/theyre-ruining-peoples-lives/bans-on-gender-affirming-care-for-transgender-youth) documenting the lived experiences behind the data. They found that bans on gender affirming care lead to:
- Increased depression, anxiety, and emotional distress.
- Disruptions in care and worsening dysphoria.
- Families taking on significant financial and logistical burdens to seek care elsewhere.
- A deep erosion of trust in healthcare systems.
These harms are not evenly distributed. Adolescents from marginalized communities—those with fewer financial resources, less flexibility to travel, or limited access to supportive care—are disproportionately impacted. This is how structural inequity gets reinforced through policy.
From a clinical perspective, none of this is surprising. Access to timely, appropriate gender affirming care improves outcomes. Barriers worsen them.
So when legislation removes access, it doesn’t create neutrality: it creates harm.
At QueerDoc, we believe in naming that clearly. Because policies that ignore evidence aren’t neutral: they actively shift risk onto the adolescents who need care the most.
What About Out-of-State Care?
HB 174 does not explicitly prohibit families from seeking care out of state. However, that doesn’t mean access is straightforward. Instead, families now face increased financial burden, travel logistics and time off work or school, and emotional stress and uncertainty.
Barriers don’t have to be outright bans to be effective. Sometimes they just make care harder to reach.
There Are Options 💜
If you’re navigating this in Utah, you are not without support.
- QueerDoc and other out-of-state clinics continue to provide gender affirming care where legally permitted.
- The Campaign for Southern Equality’s Trans Youth Emergency Project helps coordinate and fund care.
- Elevated Access assists with transportation, including flights to medical appointments.
Community is stepping up in real, tangible ways—and that matters.
The Bigger Picture
HB 174 is part of a broader trend of restricting access to transgender healthcare despite overwhelming medical consensus supporting it. At QueerDoc, we believe that healthcare decisions belong to patients, families, and clinicians—not politicians. Care should be consent-driven, evidence-based, and individualized, grounded in trust and clinical expertise. It should also be accessible, trauma-informed, and socially just, recognizing the real-world barriers many transgender and gender diverse people face. Anything less isn’t just a difference in approach, it’s a failure to meet the standard of care.
Final Thoughts
Utah had the data. They reviewed the evidence. And they chose to ignore it.
That’s not just a policy issue—it’s a signal about whose health is prioritized and whose is negotiable.
We’re not okay with that.
Trans adolescents deserve access to medically necessary, evidence-based care. Full stop.
If you or your family are navigating care in Utah, reach out to QueerDoc. We’ll help you understand your options—clearly, transparently, and without the nonsense. You can book a free 15-minute introductory appointment via the “Request Appointment” button at the top of this page.
